Francesca Manago
Genoa, 16163, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Oxytocin seals the blood-brain barrier, improving 22q11.2 deletion syndrome trajectories.
Journal: Brain : a journal of neurology
Published: November 10, 2023
Dopaminergic signalling and behavioural alterations by Comt-Dtnbp1 genetic interaction and their clinical relevance.
Journal: British journal of pharmacology
Published: June 13, 2022
Cortico-cortical transfer of socially derived information gates emotion recognition.
Journal: Nature neuroscience
Published: April 13, 2022
Dysbindin-1A modulation of astrocytic dopamine and basal ganglia dependent behaviors relevant to schizophrenia.
Journal: Molecular psychiatry
Published: January 14, 2022
Kidins220/ARMS modulates brain morphology and anxiety-like traits in adult mice.
Journal: Cell death discovery
Published: November 22, 2021
Astrocytes mediate long-lasting synaptic regulation of ventral tegmental area dopamine neurons.
Journal: Nature neuroscience
Published: March 05, 2021
Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 11, 2020
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7.
Journal: Scientific reports
Published: September 08, 2019
Favorable effects of omega-3 polyunsaturated fatty acids in attentional control and conversion rate to psychosis in 22q11.2 deletion syndrome.
Journal: Neuropharmacology
Published: August 15, 2019
SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson's Disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 25, 2019
Last Updated: 09/26/2026